Novo Nordisk: 5 πράγματα που δεν γνωρίζετε για τη νέα πλουσιότερη εταιρεία της Ευρώπης

FORTUNE

epa06425276 Signage of Danish Novo Nordisk, a world leader in making insulin, in Bagsvaerd, Denmark, 23 August 2011. Media reports on 08 January 2018 state Belgian Ablynx have rejected Novo Nordisk offer to buy the company for 3,1 billion USD, or 2,6 billion euro. The Ablynx board said thney do not think the offer matches their potential and that the offer just wasn"t enough. EPA/JENS NOERGAARD LARSEN DENMARK OUT EPA